Abstract

Quercetin is a bioflavonoid which has a broad spectrum of biological activity. Due to its lower chemical stability, it is usually encapsulated, or a metal–quercetin complex is formed to enhance its biological activity at a lower concentration. Here, our novel approach was to form a quercetin complex to magnesium-doped calcium silicate (CMS) ceramics through a coprecipitation technique so as to take advantage of quercetin’s antibacterial activity within the antibacterial and osteogenic potential of the silicate. Due to quercetin’s inherent metal-chelating ability, (Ca+Mg)/Si increased with quercetin concentration. Quercetin in magnesium-doped calcium silicate ceramic showed concentration-dependent pro-oxidant and antioxidant activity in SaOS-2 with respect to quercetin concentration. By optimizing the relative concentration, we were able to achieve 3-fold higher proliferation and 1.6-fold higher total collagen at day 14, and a 1.7-fold higher alkaline phosphatase production at day 7 with respect to polycaprolactone/polyvinylpyrrolidone (PCL/PVP) scaffold. Quercetin is effective against Gram-positive bacteria such as S. aureus. Quercetin is coupled with CMS provided similar effect with lower quercetin concentration than quercetin alone. Quercetin reduced bacterial adhesion, proliferation and biofilm formation. Therefore, quercetin-coupled magnesium-doped calcium silicate not only enhanced osteogenic potential, but also reduced bacterial adhesion and proliferation.

Highlights

  • Designing resorbable scaffolds for bone tissue engineering is a multifactorial design problem

  • The objective of this article is to investigate the effect of quercetin–calcium silicate (CMS) systems on their ability to enhance osteoblast activity using human osteosarcoma (SaOS-2) cell lines and on their ability to resist bacterial adhesion and proliferation

  • Incorporation of quercetin increased the Mg/Ca ratio in the nanoparticle, and (Ca+Mg)/Si was found to be higher for the CMSQ10 nanoparticle (Table 1)

Read more

Summary

Introduction

Designing resorbable scaffolds for bone tissue engineering is a multifactorial design problem. The current design aspect of scaffold design requires it to reduce/prevent microbial adhesion and growth and, if possible, kill the microbes, as well as aid in successful bone regeneration. Many synthetic polymers such as polycaprolactone (PCL) do not possess inherent antibacterial property. Passive resistance against bacteria can be provided by making the scaffold hydrophilic. This can be achieved by including polyvinylpyrrolidone (PVP). Other routes to incorporate antibacterial properties into scaffold can be through the addition of nanoparticle and/or through antibiotics [1]. One section of research focuses on identifying biomolecules that can offer properties such as those of antibiotics and support tissue regeneration

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call